120 results
8-K
NVTAQ
Invitae Corp
10 Mar 20
Invitae to Acquire YouScript and Genelex to Make it Easier to Use Pharmacogenetic Information at the Point of Care
4:33pm
other things and subject to the satisfaction or waiver of the conditions set forth in the YouScript Acquisition Agreement, Invitae will acquire 100 … Conditions; Closing Date
The obligations of the parties to consummate the YouScript Transactions are subject to the satisfaction or waiver of various
8-K
NVTAQ
Invitae Corp
24 Jun 20
Entry into a Material Definitive Agreement
5:08pm
of Reorganization (the “Merger Agreement”), pursuant to which, among other things, subject to the satisfaction or waiver of the conditions set forth in the Merger … to the satisfaction of customary closing conditions.
In connection with the Private Placement, the Company is expected to enter into a Registration Rights Agreement
8-K
NVTAQ
Invitae Corp
11 Jul 19
Entry into a Material Definitive Agreement
4:40pm
(the “Agreement”), pursuant to which, among other things and subject to the satisfaction or waiver of the conditions set forth in the Agreement, Invitae … to the satisfaction or waiver of various conditions set forth in the Agreement, including, but not limited to (i) the accuracy of the representations
S-8
EX-99.1
5crs hk2f7c2x3
14 Sep 21
Registration of securities for employees
4:07pm
8-K
fqt j96cqd3
17 Jun 19
Invitae to Acquire Singular Bio to Help Increase Access to Genetic Screening in Early Pregnancy
8:41am
8-K
l8v2mlp
7 Sep 21
Invitae to Acquire Ciitizen to Strengthen its Patient-Consented Health Data Platform to Improve Personal Outcomes and Global Research
8:01am
S-8
EX-99.1
44erd6xx
9 Aug 21
Registration of securities for employees
5:27pm
S-1
EX-10.5
yxozr4pd1bo
9 Jan 15
IPO registration
12:00am
8-K
68s4bi1uz96y 9p
2 May 24
Entry into a Material Definitive Agreement
4:39pm
8-K
EX-10.2
jyuz1f95
7 Nov 18
Invitae Reports 106% Annual Revenue Growth Driven by 95% Annual Growth in Volume
4:14pm
8-K
EX-10.2
ble 8qznol
5 Apr 21
Invitae Announces $1.15 Billion Investment Supporting Ongoing Growth Initiatives
4:13pm